FDA approves new psoriasis drug Taltz

ArticleGeneral

U.S. Food and Drug Administration, March 2016 Release The U.S. Food and Drug Administration today approved Taltz (ixekizumab) to treat adults with moderate-to-severe plaque psoriasis. Psoriasis is a skin condition … Read More